InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: Frnrth post# 51

Wednesday, 04/10/2019 9:14:23 AM

Wednesday, April 10, 2019 9:14:23 AM

Post# of 268
IMO after today's drop it will be. FDA denied them "Do Novo" status, but they're already underway commercializing the PoNS in Canada with a minimum of revenue of $1.6-$2MM this year based solely on the 2 signed clinics. There's only upside to that number.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HSDT News